Previous Article | Next Article 
Journal of Bacteriology, September 2000, p. 5267-5270, Vol. 182, No. 18
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Evidence for Multimerization of Neu Proteins
Involved in Polysialic Acid Synthesis in Escherichia coli
K1 Using Improved LexA-Based Vectors
Dayle A.
Daines
and
Richard P.
Silver*
Department of Microbiology and Immunology,
University of Rochester Medical Center, Rochester, New York 14642
Received 28 March 2000/Accepted 27 June 2000
 |
ABSTRACT |
Recently, M. Dmitrova et al. (Mol. Gen. Genet. 257:205-212, 1998)
described a LexA-based genetic system to monitor protein-protein interactions in an Escherichia coli background. However,
the plasmids used in this system, pMS604 and pDP804, were not readily
amenable for general use. In this report, we describe modifications of both plasmids that allow fragments of DNA to be fused to either vector
in any reading frame. Homodimerization and heterodimerization of
full-length proteins involved in polysialic acid synthesis in E. coli K1, as well as heterodimerization between a full-length protein and a protein fragment, demonstrate the usefulness of the
modified plasmids for investigating bacterial protein-protein interactions in vivo.
 |
TEXT |
The K1 capsule of Escherichia
coli is a linear homopolymer of
-(2,8)-linked
N-acetylneuraminic acid (NeuNAc; sialic acid) (15,
17). The capsule is identical to the polysialic acid (polySia)
found on human embryonic nerve cell adhesion molecules and is poorly
immunogenic due to the molecular mimicry of host structures
(17). Surface-displayed sialic acid also confers resistance
to the alternative complement pathway, allowing E. coli to
establish extraintestinal infections such as neonatal septicemia and
meningitis (15, 17).
The genes for the biosynthesis and transport of the K1 capsule are
encoded on the 17-kb kps gene cluster, which is functionally divided into three regions (4, 21, 23). The genes in regions 1 and 3, designated kps, are conserved among E. coli strains that synthesize serologically distinct capsules and
are involved with transport of the polymer to the bacterial cell
surface (4, 21, 23). In contrast, the genes in region 2 are
unique to a given capsular type. In E. coli K1, region 2 encodes the neuDBACES genes, which direct the synthesis,
activation, and polymerization of NeuNAc (4).
Biosynthesis of polySia in E. coli K1 involves the
NeuB-catalyzed condensation of N-acetylmannosamine (ManNAc)
and phosphoenolpyruvate to form NeuNAc (20). ManNAc is
provided by the neuC gene product, a UDP-GlcNAc
2-epimerase (D. A. Daines, W. F. Vann, D. O. Chaffin, C. E. Rubens, and R. P. Silver, submitted for
publication). NeuD is also required for NeuNAc synthesis, although its
enzymatic role remains an enigma (5a).
Activation of NeuNAc is performed by NeuA, which adds a
nucleotide monophosphate to the sugar to form CMP-NeuNAc
(19). NeuS is the sialyltransferase, polymerizing
activated CMP-NeuNAc to polySia (16).
The current view of polymer synthesis and assembly assumes that the
components of the kps cluster form a hetero-oligomeric protein complex (4, 13). Identification and characterization of the protein-protein interactions involved in this complex are crucial to our understanding of the mechanism of polymer synthesis and
transport. Recently, a LexA-based genetic system for studying protein-protein interactions in an E. coli background was
reported (6). The LexA repressor is an important component
in the regulation of SOS response genes (14). The protein
consists of two domains, a DNA-binding domain (DBD) and a dimerization
domain. Although a truncated LexA consisting of only the DBD can
recognize its operator sequence, it is functional as a transcriptional
repressor only in dimeric form. Other domains can be fused in
frame to the DBD and will restore the repressor's function if
these domains interact. The LexA-based system described by
Dmitrova et al. (6) consists of two compatible plasmids
carrying either a wild-type (pMS604) or a mutant (pDP804)
lexA DBD gene fragment. The mutant LexA DBD contains three
amino acid changes that allow it to recognize a mutant operator. The
plasmids were used in two E. coli reporter strains, SU101
and SU202. SU101 has a wild-type LexA operator sequence upstream of a
lacZ reporter gene expressed by the sulA promoter
engineered in the chromosome, while SU202 has the same reporter system
but is controlled by a hybrid LexA operator sequence (6).
Since sulA is one of the most repressed genes of the SOS response, LexA binds the sulA operator more tightly than the
other natural SOS operators (14). A wild-type LexA fusion
homodimer recognizes the wild-type operator in SU101 and represses
reporter gene transcription, but only a heterodimer of a wild-type and a mutant LexA DBD fusion can recognize the hybrid operator in SU202.
This allowed both homo- and hetero-association of protein fusions to be
monitored. The system was tested for heterodimerization using
the leucine zipper domains of the eukaryotic proteins Jun (pDP804) and Fos (pMS604). Although the focus of the study was protein
heterodimerization, Dmitrova et al. (6) also analyzed homodimerization by fusing a Fos zipper region mutated so that it could
interact with itself to the wild-type LexA DBD.
Plasmids pMS604 and pDP804 carry the Fos and Jun leucine zipper
domains, respectively, and were not readily amenable for general use.
In this report we describe modifications of both plasmids that allow
fragments of DNA to be fused to either vector in any reading frame. We
demonstrate the usefulness of the modified plasmids for investigating
bacterial protein-protein interactions in vivo by demonstrating
homodimerization of full-length NeuD, NeuA, NeuC, and NeuB as well
as heterodimerization between NeuD and NeuB.
Modification of pDP804 and pMS604.
Plasmid pDP804 carries the
p15A origin of replication and an ampicillin resistance gene. Plasmid
pMS604 has a ColE1 origin of replication and a tetracycline resistance
gene (6). In each plasmid, a lac promoter
controls expression of the gene encoding the wild-type or mutant LexA
DBD fused to the leucine zipper region of the Fos or Jun protein,
respectively, and is therefore inducible by
isopropyl-
-D-thiogalactopyranoside (IPTG)
(6). To remove the Fos leucine zipper fusion, pMS604 was
digested with the restriction endonucleases PinAI
(AgeI) and XhoI and gel purified by standard procedures (2). Plasmid pDP804 was subjected to
identical procedures, except that the restriction endonucleases were
BssHII and BamHI. PCR-generated fragments of the
multiple cloning sites (MCS) from the vectors pTrcHisA, pTrcHisB, and
pTrcHisC (Invitrogen, Carlsbad, Calif.) with compatible restriction
sites were ligated to the purified vector DNA. The six plasmids created
allow fragments of DNA to be fused to either the wild-type or the
mutant LexA DBD in any of three reading frames (Fig.
1). The pMS604 (wild type)-based plasmids
are pSR658, pSR660, and pSR662, carrying the MCS of pTrcHisA, -B, and
-C, respectively. The pDP804 (mutant)-based plasmids are pSR659,
pSR661, and pSR663, which carry MCS-A, MCS-B, and MCS-C, respectively.
Details of constructions and sequences of the vectors can be obtained
from R. P. Silver. Using the modified plasmids, an entire gene or
region of interest can be fused to the wild-type LexA DBD, and
homodimerization can be monitored by lacZ reporter gene
transcriptional repression in SU101 via
-galactosidase activity
assays. Alternatively, genes encoding two different domains or proteins
can be fused to the wild-type and mutant LexA DBD in the proper frame,
and heterodimerization occurring in SU202 can be quantitated in the
same fashion (Fig. 1). In this study we used pSR658, carrying the
wild-type LexA DBD, and pSR659, expressing the mutant LexA DBD.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
Modified LexA-based system for investigating
protein-protein interactions. The LexA-based system was based on that
of Dmitrova et al. (6). A homodimerizing fusion expressed
from one of the wild-type (wt) LexA DBD::MCS plasmids
(pSR658, pSR660, or pSR662) will bind to the wild-type LexA operator
and repress expression of lacZ in the chromosome of the
reporter strain SU101. A heterodimerizing fusion, one subunit expressed
from one of the wild-type LexA DBD::MCS plasmids and the
other from one of the mutated (mut) LexA DBD::MCS plasmids
(pSR659, pSR661, or pSR663), will bind to the hybrid LexA operator and
repress expression of lacZ in the chromosome of the reporter
strain SU202. The choice of plasmid MCS (A, B, or C) is made according
to the reading frame of the desired fusion. Wild-type and mutated
DBD correspond to LexA1-87WT and
LexA1-87408, respectively (6).
|
|
Full-length protein fusions can homodimerize.
The four genes
involved in the synthesis and activation of sialic acid in E. coli K1, neuA, neuB, neuC, and
neuD, were fused in frame to the wild-type LexA DBD in
pSR658. To determine that the plasmids were expressing protein when
induced, we performed a Western blot analysis using induced SU101 cells
carrying each plasmid grown to stationary phase in 1 mM IPTG.
Twenty-microliter aliquots of cells were pelleted, resuspended in 15 µl of 2× sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) sample buffer with
-mercaptoethanol, and incubated at
95°C for 5 min. The samples were resolved by SDS-PAGE on a 12%
polyacrylamide gel. After separation, the proteins were transferred to
a nitrocellulose membrane (Bio-Rad Laboratories, Hercules, Calif.) and
probed with anti-LexA antibody (Invitrogen), using standard procedures
(2). The blot was detected using an enhanced
chemiluminescence detection system (Amersham Pharmacia Biotech,
Piscataway, N.J.). The LexA fusions added approximately 9.6 kDa to the
protein of interest. All full-length neu gene fusions were
expressed, and their mobilities on an SDS-polyacrylamide gel exhibited
the expected pattern (Fig. 2).

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 2.
Immunoblot of LexA-Neu fusions. Full-length E. coli K1 region 2 genes were ligated into pSR658. An immunoblot of
crude lysates of induced stationary-phase cultures probed with
anti-LexA antiserum (Invitrogen) is shown. The calculated
molecular masses in kilodaltons for the wild-type and LexA fusions,
respectively, are in parentheses. Lane 1, LexA::NeuD (22.2, 31.8); lane 2, LexA::NeuC (43.1, 52.7); lane 3, LexA::NeuB (38.1, 47.7); lane 4, LexA::NeuA (45.8, 55.4). Molecular mass markers in kilodaltons appear at the left.
|
|
To determine whether the LexA fusions were functional, we tested their
ability to complement a K-12-K1 hybrid strain with
a deletion or
interruption in the gene of interest. Each retained
the ability to
restore capsule synthesis when placed in
trans in the
corresponding acapsular mutant strain, indicating that
the
87-amino-acid LexA DBD fused to the amino terminus of each
protein did
not interfere with its activity in vivo (data not
shown). A
capsule-positive phenotype was determined by sensitivity
to
capsule-specific phage (K1F) and by haloes of precipitated
antigen-antibody complexes on agar plates supplemented with horse
antiserum raised against the

-(2,8)-polysialic acid capsule (H.46)
(
22).
Measuring repression of

-galactosidase activity in induced cells of
strain SU101 carrying each fusion allowed quantitation
of
homodimerization of full-length proteins fused to the wild-type
LexA
DBD in pSR658. For these experiments, only those fusion proteins
that
repressed expression of

-galactosidase at a level that resulted
in a
pale colony color of the reporter strain on MacConkey agar
plates were
considered to be interacting efficiently. Quantitatively,
the amount of
repression required to display a discernibly different
colony color was
on average

25% of the control level. Cells were
grown to stationary
phase with the appropriate antibiotics and
1 mM IPTG. Then 100 µl of
each culture was used to inoculate 2
ml of fresh Luria-Bertani medium
with IPTG and antibiotics. The
cultures were grown to log phase and
harvested;

-Galactosidase
activity was determined as described by
Miller (
10). The units
were calculated from the results of
at least three independent
cultures assayed in triplicate. Percent
repression relative to
the control cultures was calculated as
[1.0

(Miller units of
sample/Miller units of control)] × 100. The CMP-NeuNAc synthase
protein, NeuA, fused to wild-type LexA DBD
repressed

-galactosidase
activity by an average of 78%, compared to
SU101 with pSR658 alone
(Table
1). This
is consistent with the observation that NeuA
is enzymatically active as
a dimer (W. F. Vann and D. Stoughton,
unpublished data). The NeuC
fusion repressed at 68%, while NeuB,
NeuNAc synthase, repressed
expression of

-galactosidase by 39%.
The fusion with NeuD was the
most efficient of the capsule synthesis
proteins, exhibiting 87%
repression. NeuD belongs to a family
of acetyl- or acyltransferases
that includes LpxA, LacA, and CysE
(
1,
7,
18). Like other
members of this family, NeuD contains
a signature hexapeptide repeat
motif referred to as an isoleucine
patch (
7,
18). The
crystal structures of three hexapeptide
proteins have been determined;
they each form trimers and share
a unique structural feature known as a
left-handed parallel
helix (
3,
14). NeuD also forms
trimers of identical subunits
in vivo (
5). These
observations are consistent with the high
level of NeuD
homodimerization observed with the LexA system.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Homodimerization of full-length proteins and protein
fragments fused to the wild-type LexA DNA-binding domain (DBD)
in pSR658
|
|
The ability of multimeric fusion proteins to repress

-galactosidase
expression in this system was confirmed by fusing a gene
encoding the
type I chloramphenicol acetyltransferase from Tn
9 to the
LexA DBD in pSR658. Chloramphenicol acetyltransferase is
a
well-characterized homotrimer and belongs to the same family
of acetyl-
or acyltransferases as NeuD. This construct conferred
chloramphenicol
resistance to DH5

cells, and its expression was
detected via
immunoblot using anti-LexA antiserum (data not shown).
The fusion
protein repressed

-galactosidase expression in SU101
by 94% (Table
1). The reporter strain SU101 contains a Tn
9 insertion
in
its chromosomal copy of
lacZ and constitutively expresses
unfused
type I chloramphenicol acetyltransferase subunits. The high
level
of repression that we observed indicates that the modified
LexA-based
system is useful in determining interactions between fusion
proteins
even in the presence of wild-type subunits expressed by the
host
cell.
Fragments of neu genes do not homodimerize
efficiently.
In contrast to the results with full-length protein
fusions, fragments of the neu genes did not yield fusion
proteins that homodimerized as efficiently. For these experiments,
three fragments of neuD (neuD1 to
neuD3) and a fragment (neuA1) encoding the
amino-terminal 250 amino acids of neuA (Table 1) were
amplified by PCR and fused to pSR658 in frame with the LexA DBD. These
plasmids were then used to transform SU101. Since the fragment fusions
could not be identified by complementation, the transformants were
selected via antibiotic resistance and the inserts were confirmed by
colony PCR with primers that flanked the region of interest, by
restriction endonuclease digests of purified plasmid preparations, and
by DNA sequencing. We were unable to detect the fragment fusions on a
Western blot probed with anti-LexA antiserum. The inability to detect
small fusions on an immunoblot was also reported by Enz et al. in their
study of FecA and FecR fragments replacing the Jun and Fos zipper
regions in the parent vectors pDP804 and pMS604 (8).
However, the ability of the NeuD2 fragment to heterodimerize with NeuB
(see below) indicates that the NeuD2 fragment fusion was expressed.
Moreover, the NeuA1, NeuD1, and NeuD3 fusions were positive on a dot
blot probed with anti-LexA antiserum (data not shown). While this does
not confirm the size of the small fragment fusions, it does establish
that they are indeed expressed.
Unlike the full-length NeuA fusion, the NeuA1 fusion did not
homodimerize, as reflected by its inability to efficiently repress

-galactosidase expression (Table
1). Interestingly, a truncated
protein encoding the first 250 amino acids of NeuA displayed
approximately
10% of the enzymatic activity of the full-length enzyme
in vitro
and formed only transient dimers (Vann and Stoughton,
unpublished).
The NeuD fragment fusions each repressed

-galactosidase expression
at a much lower level than full-length
NeuD (Table
1). Fragmentation
of NeuD likely resulted in the inability
of the fusions to fold
properly, and as a result they homodimerized
poorly.
NeuB and NeuD interact in vivo.
The data in Table 1
indicate that the LexA-based system can be used to study
homodimerization of full-length proteins. To investigate the
suitability of the modified LexA system to study the protein-protein
interactions among different components of the kps complex,
we examined the interaction between the NeuD and NeuB proteins. Both
proteins are involved in sialic acid synthesis and are likely to form a
complex in vivo (13). For these experiments, full-length
neuB and neuD genes, as well as fragments of
neuD, were fused in frame to either the wild-type (pSR658)
or mutant (pSR659) lexA DBD and introduced into the reporter
strain SU202. As shown in Table 2, we
observed significant interaction between NeuD and NeuB, quantitated as
71% repression of
-galactosidase activity, in cells harboring the
NeuB fusion expressed from the high-copy-number vector, pSR658, and a
NeuD fusion in the lower-copy-number vector, pSR659.
The interaction between NeuB and NeuD was further investigated by
assaying

-galactosidase expression in SU202 harboring the
full-length NeuB fusion in pSR658 and pSR659 carrying fragments
of
NeuD. Only one NeuD fragment, NeuD2, displayed interaction
approaching that of full-length NeuD with the full-length NeuB
fusion.
Fragment NeuD2, when expressed from pSR659, repressed

-galactosidase
expression 66%.
These data suggest that NeuD and NeuB interact in vivo and that amino
acid residues 90 to 207 of the NeuD protein are important
for this
interaction. However, the formation of heterodimers by
two proteins is
not necessarily straightforward when one of the
proteins, like NeuD, is
able to form homodimers, and we did observe
conflicting results with
the reciprocal experiment. When the
neuD gene, fused to the
lexA DBD in pSR658 was introduced into SU202
harboring
neuB fused to the mutant
lexA DBD in pSR659,
little
repression of

-galactosidase activity was seen (Table
2). We
postulate that when NeuD is expressed from pSR658, the high-copy-number
vector, it is more likely to form homodimers and less likely to
interact with NeuB and repress the hybrid promoter in SU202. This
view
is supported by the observation that the NeuD2 fragment of
NeuD, which,
in contrast to the full-length protein, is unable
to efficiently
homodimerize (Table
1), effectively interacted
with NeuB even when
expressed from the higher-copy-number vector
(Table
2). This was
reflected in 49% repression of

-galactosidase
activity.
Conclusions.
In this communication we describe the use of a
modified LexA-based genetic system to investigate, in vivo, the
interactions between proteins that comprise a putative
hetero-oligomeric complex responsible for K1 capsule synthesis (4,
13). Both homo- and heterodimerization of protein fusions were
detected. This system allows determination of the heterodimerization of
two fusion proteins even when one protein homodimerizes strongly, as is
the case with NeuD. The system can also reveal the interaction of fusion proteins in the presence of unfused subunits expressed by the
host cell, as shown by the chloramphenicol acetyltransferase experiment. Only those fusion proteins that repressed expression of
-galactosidase at a level that resulted in a pale colony color of
the reporter strain on MacConkey agar plates (
25% of the controls) were considered to be interacting efficiently. That is not to say,
however, that repression below 25% may not be biologically significant. However, the limitations of any LexA-based system include
difficulty in deducing weak or transient interactions, steric hindrance
by the fusion moiety, and sequestration of the fused moiety into an
intracellular complex (9). Moreover, the inability to detect
heterodimerization does not preclude association of a given protein
with a higher-order multimer of another protein. It is unlikely that
such interactions would be detected in this system. The different copy
numbers of the vectors, although useful in determining the
heterodimerization of a strongly homodimerizing protein by allowing
reciprocal fusions, add a level of complexity to the system, and it is
recommended that any putative heterodimerizing fusions also be assayed
when expressed from the opposite vector pair. It is also possible that
overexpression of a wild-type LexA fusion that strongly homodimerizes,
may, to some degree, overcome the low affinity of the wild-type LexA
DBD for the hybrid operator in SU202. With these limitations in mind,
we consider this modified system a fast, economical, and reproducible
tool to initially screen for possible interactions and to be suitable
for use in conjunction with biochemical methods for demonstrating
protein-protein interactions, such as gel filtration and protein
cross-linking.
 |
ACKNOWLEDGMENTS |
We are extremely grateful to M. Granger-Schnarr for her kind gift
of plasmids pDP804 and pMS604 and the reporter strains SU101 and SU202.
We also thank Virginia Clark, Marty Pavelka, and Lou Passador for
critically reviewing the manuscript.
This work was supported by NIH grants AI39615 to R.P.S. D.A.D. was
supported by Molecular Pathogenesis of Bacteria and Viruses training
grant AI07362 from the Public Health Service.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: University of
Rochester Medical Center, Department of Microbiology and Immunology, 601 Elmwood Ave., Box 672, Rochester, NY 14642. Phone: (716) 275-0680. Fax: (716) 473-9573. E-mail:
rips{at}uhura.cc.rochester.edu.
Present address: Department of Molecular Microbiology and
Immunology, University of Missouri
Columbia, Columbia, MO 65212.
 |
REFERENCES |
| 1.
|
Annunziato, P. W.,
L. F. Wright,
W. F. Vann, and R. P. Silver.
1995.
Nucleotide sequence and genetic analysis of the neuD and neuB genes in region 2 of the polysialic acid gene cluster of Escherichia coli K1.
J. Bacteriol.
177:312-319[Abstract/Free Full Text].
|
| 2.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl (ed.).
1989.
Current protocols in molecular biology, vol. 2.
John Wiley & Sons, New York, N.Y.
|
| 3.
|
Beaman, T. W.,
M. Sugantino, and S. L. Roderick.
1998.
Structure of the hexapeptide xenobiotic acetyltransferase from Pseudomonas aeruginosa.
Biochemistry
37:6689-6696[CrossRef][Medline].
|
| 4.
|
Bliss, J. M., and R. P. Silver.
1996.
Coating the surface: a model for expression of capsular polysialic acid in Escherichia coli K1.
Mol. Microbiol.
21:221-231[CrossRef][Medline].
|
| 5.
|
Daines, D. A.
1999.
Ph.D. thesis.
University of Rochester, Rochester, N.Y.
|
| 5a.
|
Daines, D. A.,
L. F. Wright,
D. O. Chaffin,
C. E. Rubens, and R. P. Silver.
2000.
NeuD plays a role in the synthesis of sialic acid in Escherichia coli K1.
FEMS Microbiol. Lett.
189:281-284[CrossRef][Medline].
|
| 6.
|
Dmitrova, M.,
G. Younes-Cauet,
P. Oertel-Buchheit,
D. Porte,
M. Schnarr, and M. Granger-Schnarr.
1998.
A new LexA-based genetic system for monitoring and analyzing protein heterodimerization in Escherichia coli.
Mol. Gen. Genet.
257:205-212[CrossRef][Medline].
|
| 7.
|
Downie, J. A.
1989.
The nodL gene from Rhizobium leguminosarum is homologous to the acetyltransferases encoded by lacA and cysE.
Mol. Microbiol.
3:1649-1651[Medline].
|
| 8.
|
Enz, S.,
S. Mahren,
U. H. Stroeher, and V. Braun.
2000.
Surface signaling in ferric citrate transport gene induction: interaction of the FecA, FecR, and FecI regulatory proteins.
J. Bacteriol.
182:637-646[Abstract/Free Full Text].
|
| 9.
|
Golemis, E. A., and R. Brent.
1992.
Fused protein domains inhibit DNA binding by LexA.
Mol. Cell. Biol.
12:3006-3014[Abstract/Free Full Text].
|
| 10.
|
Miller, J. H.
1992.
A short course in bacterial genetics.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 11.
|
Moxon, E. R., and J. S. Kroll.
1990.
The role of bacterial polysaccharide capsules as virulence factors.
Curr. Top. Microbiol. Immunol.
150:65-85[Medline].
|
| 12.
|
Raetz, C. R. H., and S. L. Roderick.
1995.
A left-handed parallel helix in the structure of UDP-N-acetylglucosamine acyltransferase.
Science
270:997-1000[Abstract/Free Full Text].
|
| 13.
|
Rigg, G. P.,
B. Barrett, and I. S. Roberts.
1998.
The localization of KpsC, S and T, and KfiA, C and D proteins involved in the biosynthesis of the Escherichia coli K5 capsular polysaccharide: evidence for a membrane-bound complex.
Microbiology
144:2905-2914[Abstract/Free Full Text].
|
| 14.
|
Schnarr, M., and M. Granger-Schnarr.
1993.
LexA, the self-cleaving transcriptional repressor of the SOS system.
Nucleic Acids and Mol. Biol.
7:170-189.
|
| 15.
|
Silver, R. P., and E. R. Vimr.
1990.
Polysialic acid capsule of Escherichia coli K1, p. 39-60.
In
B. H. Iglewski, and V. L. Clark (ed.), Molecular basis of microbial pathogenesis. Academic Press, Inc., San Diego, Calif.
|
| 16.
|
Steenbergen, S. M.,
T. J. Wrona, and E. R. Vimr.
1992.
Functional analysis of the sialyltransferase complexes in Escherichia coli K1 and K92.
J. Bacteriol.
174:1099-1108[Abstract/Free Full Text].
|
| 17.
|
Troy, F. A.
1992.
Polysialylation: from bacteria to brains.
Glycobiology
2:5-23[Free Full Text].
|
| 18.
|
Vaara, M.
1992.
Eight bacterial proteins, including UDP-N-acetylglucosamine acyltransferase (LpxA) and three other transferases of Escherichia coli, consist of a six-residue periodicity theme.
FEMS Microbiol. Lett.
97:249-254[CrossRef].
|
| 19.
|
Vann, W. F.,
R. P. Silver,
C. Abeijon,
K. Chang,
W. Aaronson,
A. Sutton,
C. W. Finn,
W. Linder, and M. Kotsatos.
1987.
Purification, properties, and genetic location of Escherichia coli cytidine 5'-monophosphate N-acetylneuraminic acid synthetase.
J. Biol. Chem.
262:17556-17562[Abstract/Free Full Text].
|
| 20.
|
Vann, W. F.,
J. J. Tavarez,
J. Crowley,
E. Vimr, and R. P. Silver.
1997.
Purification and characterization of the Escherichia coli K1 neuB gene product N-acetylneuraminic acid synthetase.
Glycobiology
7:697-701[Abstract/Free Full Text].
|
| 21.
|
Vimr, E.,
S. Steenbergen, and M. Cieslewicz.
1995.
Biosynthesis of the polysialic acid capsule in Escherichia coli K1.
J. Ind. Microbiol.
15:352-360[CrossRef][Medline].
|
| 22.
|
Vimr, E. R.,
W. Aaronson, and R. P. Silver.
1989.
Genetic analysis of chromosomal mutations in the polysialic acid gene cluster of Escherichia coli K1.
J. Bacteriol.
172:1106-1117.
|
| 23.
|
Whitfield, C., and I. S. Roberts.
1999.
Structure, assembly and regulation of expression of capsules in Escherichia coli.
Mol. Microbiol.
31:1307-1319[CrossRef][Medline].
|
Journal of Bacteriology, September 2000, p. 5267-5270, Vol. 182, No. 18
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Fuhrmann, E., Bultema, J. B., Kahmann, U., Rupprecht, E., Boekema, E. J., Schneider, D.
(2009). The Vesicle-inducing Protein 1 from Synechocystis sp. PCC 6803 Organizes into Diverse Higher-Ordered Ring Structures. Mol. Biol. Cell
20: 4620-4628
[Abstract]
[Full Text]
-
Vimr, E. R., Steenbergen, S. M.
(2009). Early molecular-recognition events in the synthesis and export of group 2 capsular polysaccharides. Microbiology
155: 9-15
[Abstract]
[Full Text]
-
Kiratisin, P., Sanmee, S.
(2008). Roles and Interactions of Burkholderia pseudomallei BpsIR Quorum-Sensing System Determinants. J. Bacteriol.
190: 7291-7297
[Abstract]
[Full Text]
-
Purins, L., Van Den Bosch, L., Richardson, V., Morona, R.
(2008). Coiled-coil regions play a role in the function of the Shigella flexneri O-antigen chain length regulator WzzpHS2. Microbiology
154: 1104-1116
[Abstract]
[Full Text]
-
Tripathi, S. A., Taylor, R. K.
(2007). Membrane Association and Multimerization of TcpT, the Cognate ATPase Ortholog of the Vibrio cholerae Toxin-Coregulated-Pilus Biogenesis Apparatus. J. Bacteriol.
189: 4401-4409
[Abstract]
[Full Text]
-
Steenbergen, S. M., Lee, Y.-C., Vann, W. F., Vionnet, J., Wright, L. F., Vimr, E. R.
(2006). Separate Pathways for O Acetylation of Polymeric and Monomeric Sialic Acids and Identification of Sialyl O-Acetyl Esterase in Escherichia coli K1.. J. Bacteriol.
188: 6195-6206
[Abstract]
[Full Text]
-
Lewis, A. L., Hensler, M. E., Varki, A., Nizet, V.
(2006). The Group B Streptococcal Sialic Acid O-Acetyltransferase Is Encoded by neuD, a Conserved Component of Bacterial Sialic Acid Biosynthetic Gene Clusters. J. Biol. Chem.
281: 11186-11192
[Abstract]
[Full Text]
-
Chuanchuen, R., Gaynor, J. B., Karkhoff-Schweizer, R., Schweizer, H. P.
(2005). Molecular Characterization of MexL, the Transcriptional Repressor of the mexJK Multidrug Efflux Operon in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
49: 1844-1851
[Abstract]
[Full Text]
-
Elderkin, S., Bordes, P., Jones, S., Rappas, M., Buck, M.
(2005). Molecular Determinants for PspA-Mediated Repression of the AAA Transcriptional Activator PspF. J. Bacteriol.
187: 3238-3248
[Abstract]
[Full Text]
-
Deszo, E. L., Steenbergen, S. M., Freedberg, D. I., Vimr, E. R.
(2005). Escherichia coli K1 polysialic acid O-acetyltransferase gene, neuO, and the mechanism of capsule form variation involving a mobile contingency locus. Proc. Natl. Acad. Sci. USA
102: 5564-5569
[Abstract]
[Full Text]
-
Feng, L., Senchenkova, S. N., Tao, J., Shashkov, A. S., Liu, B., Shevelev, S. D., Reeves, P. R., Xu, J., Knirel, Y. A., Wang, L.
(2005). Structural and Genetic Characterization of Enterohemorrhagic Escherichia coli O145 O Antigen and Development of an O145 Serogroup-Specific PCR Assay. J. Bacteriol.
187: 758-764
[Abstract]
[Full Text]
-
Schneider, D., Engelman, D. M.
(2004). Involvement of Transmembrane Domain Interactions in Signal Transduction by {alpha}/{beta} Integrins. J. Biol. Chem.
279: 9840-9846
[Abstract]
[Full Text]
-
Vimr, E. R., Kalivoda, K. A., Deszo, E. L., Steenbergen, S. M.
(2004). Diversity of Microbial Sialic Acid Metabolism. Microbiol. Mol. Biol. Rev.
68: 132-153
[Abstract]
[Full Text]
-
Lamb, J. R., Patel, H., Montminy, T., Wagner, V. E., Iglewski, B. H.
(2003). Functional Domains of the RhlR Transcriptional Regulator of Pseudomonas aeruginosa. J. Bacteriol.
185: 7129-7139
[Abstract]
[Full Text]
-
Ibarra, J. A., Villalba, M. I., Puente, J. L.
(2003). Identification of the DNA Binding Sites of PerA, the Transcriptional Activator of the bfp and per Operons in Enteropathogenic Escherichia coli. J. Bacteriol.
185: 2835-2847
[Abstract]
[Full Text]
-
Schneider, D., Engelman, D. M.
(2003). GALLEX, a Measurement of Heterologous Association of Transmembrane Helices in a Biological Membrane. J. Biol. Chem.
278: 3105-3111
[Abstract]
[Full Text]
-
Kiratisin, P., Tucker, K. D., Passador, L.
(2002). LasR, a Transcriptional Activator of Pseudomonas aeruginosa Virulence Genes, Functions as a Multimer. J. Bacteriol.
184: 4912-4919
[Abstract]
[Full Text]